A new simple morphology‐based risk score is prognostic in stage I/II colon cancers

A portion of stage I/II colon cancers (10–20%) exhibit an adverse clinical course. The administration of adjuvant chemotherapy is recommended only in certain high‐risk situations. However, these risk factors recently failed to predict benefit from adjuvant therapy. We composed a new morphology‐based...

Descripción completa

Detalles Bibliográficos
Autores principales: Märkl, Bruno, Märkl, Maximilian, Schaller, Tina, Mayr, Patrick, Schenkirsch, Gerhard, Kriening, Bernadette, Anthuber, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867555/
https://www.ncbi.nlm.nih.gov/pubmed/27167601
http://dx.doi.org/10.1002/cam4.737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867555/
https://www.ncbi.nlm.nih.gov/pubmed/27167601
http://dx.doi.org/10.1002/cam4.737

Ejemplares similares